895 related articles for article (PubMed ID: 16085959)
1. [Kawasaki disease in children--9 years experience].
Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
[TBL] [Abstract][Full Text] [Related]
2. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
Abushaban L; Salama A; Uthaman B; Kumar A; Selvan J
Int J Cardiol; 1999 Apr; 69(1):71-6. PubMed ID: 10362375
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
4. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
[TBL] [Abstract][Full Text] [Related]
5. Giant aneurysms: A gender-specific complication of Kawasaki disease?
Dietz SM; Kuipers IM; Tacke CEA; Koole JCD; Hutten BA; Kuijpers TW
J Cardiol; 2017 Oct; 70(4):359-365. PubMed ID: 28325522
[TBL] [Abstract][Full Text] [Related]
6. Kawasaki disease in infants less than one year of age.
Rosenfeld EA; Corydon KE; Shulman ST
J Pediatr; 1995 Apr; 126(4):524-9. PubMed ID: 7699529
[TBL] [Abstract][Full Text] [Related]
7. [Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].
Calabri GB; Falcini F; Favilli S; Pollini I; Capuzzo L; Simonini G; De Simone L
Pediatr Med Chir; 2002; 24(5):352-7; discussion 397-9. PubMed ID: 12494535
[TBL] [Abstract][Full Text] [Related]
8. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.
Dionne A; Burns JC; Dahdah N; Tremoulet AH; Gauvreau K; de Ferranti SD; Baker AL; Son MB; Gould P; Fournier A; Newburger JW; Friedman KG
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31048414
[TBL] [Abstract][Full Text] [Related]
9. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
[TBL] [Abstract][Full Text] [Related]
10. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P
Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139
[TBL] [Abstract][Full Text] [Related]
11. [Six Kawasaki disease patients with acute coronary artery thrombosis].
Zhou SL; Luo JP; Qi YQ; Liang YG; Wang W; Gong FQ
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):925-9. PubMed ID: 24495764
[TBL] [Abstract][Full Text] [Related]
12. The Harada score in the US population of children with Kawasaki disease.
Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
[TBL] [Abstract][Full Text] [Related]
13. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
Michihata N; Matsui H; Fushimi K; Yasunaga H
Clin Pediatr (Phila); 2015 Oct; 54(11):1076-80. PubMed ID: 25573948
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
[TBL] [Abstract][Full Text] [Related]
15. Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.
Bachlava E; Loukopoulou S; Karanasios E; Chrousos G; Michos A
Int J Cardiol; 2016 Oct; 220():65-9. PubMed ID: 27372045
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA;
Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; ; ; ;
Circulation; 2004 Oct; 110(17):2747-71. PubMed ID: 15505111
[TBL] [Abstract][Full Text] [Related]
18. Kawasaki disease in Jordan: demographics, presentation, and outcome.
Al-Ammouri I; Al-Wahsh S; Khuri-Bulos N
Cardiol Young; 2012 Aug; 22(4):390-5. PubMed ID: 22067065
[TBL] [Abstract][Full Text] [Related]
19. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
O'connor MJ; Saulsbury FT
Clin Pediatr (Phila); 2007 May; 46(4):345-8. PubMed ID: 17475994
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with progression and persistence of small- and medium-sized coronary artery aneurysms in Kawasaki disease: a prospective cohort study.
Liu L; Luo C; Hua Y; Wu M; Shao S; Liu X; Zhou K; Wang C
Eur J Pediatr; 2020 Jun; 179(6):891-900. PubMed ID: 31980953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
